Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 345 of 5804
-
New spinal fluid test aims to solve dementia misdiagnosis puzzle
Diagnosis Not yet recruitingAlzheimer's disease and dementia with Lewy bodies (DLB) are the two main age-related neurodegenerative cognitive disorders. Differential diagnosis between these conditions is challenging, both at the prodromal and dementia stages. The lack of a precise diagnosis can be particular…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 26, 2026 16:49 UTC
-
New combo therapy aims to boost radiation for tough pancreatic tumors
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability and efficacy of XER-001 and identify a best dose for future studies.
Phase: PHASE1, PHASE2 • Sponsor: Xerient Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Simple fluid test could replace needle biopsy for TB of the lung lining
Diagnosis Not yet recruitingTuberculosis (TB) is an endemic infectious disease in Hong Kong and a global health threat. Tuberculous pleuritis (TBP) is the most common form of extrapulmonary tuberculosis in China. Its presentation is frequently non-specific and the diagnosis is challenging due to its pauciba…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Massive french study to test if RSV antibody shot stops childhood wheezing
Prevention Not yet recruitingEarly respiratory syncytial virus (RSV) bronchiolitis is a well-known contributing factor of mid- and long-term respiratory sequelae in children such as recurrent lower tract respiratory infections (LRTIs), preschool wheezing (PW) or decreased lung function at older ages. Nirsev…
Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 08:09 UTC
-
New drug duo aims to shrink stomach tumors before surgery
Disease control Not yet recruitingThe goal of this randomized, open-label, phase II clinical trial is to determine whether adding the PD-1/CTLA-4 bispecific antibody QL1706 to standard SOX chemotherapy increases the pathological complete response rate in adults aged 18-75 years with resectable, locally advanced, …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy aims to control returning throat cancer
Disease control Not yet recruitingThis study enrolls patients who have experienced local recurrence of nasopharyngeal carcinoma (NPC) with or without regional recurrence. The treatment regimen includes an induction phase with MRG003 at 2.0 mg/kg (D1) combined with Tislelizumab 200 mg (D1), administered weekly for…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for rare cancers: china launches massive drug trial
Disease control Not yet recruitingThe goal of this Phase I/II observational and interventional platform study is to evaluate the safety and efficacy of multiple types of innovative anti-tumor drugs and new technologies in patients with rare solid tumors. The study utilizes multi-dimensional precision screening (i…
Phase: PHASE1, PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for hard-to-treat breast cancer: combo therapy enters human trials
Disease control Not yet recruitingThis is a multicenter, open-label, Phase Ib/II randomized study designed to evaluate the safety, tolerability, dose-limiting toxicities (DLTs), and preliminary antitumor activity of JSKN016 in combination with the oral selective estrogen receptor degrader (SERD) D-0502 in patient…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug cocktail shows promise for rare head and neck cancer
Disease control Not yet recruitingThis study aims to conduct a prospective clinical trial investigating the use of pucotenlimab in combination with lenvatinib and temozolomide as neoadjuvant and postoperative adjuvant therapy for resectable oral and head and neck mucosal melanoma. The primary objectives are to ev…
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Immune cells engineered to fight lupus enter first human tests
Disease control Not yet recruitingThe goal of this clinical trial is to learn about the safety, pharmacokinetics and pharmacodynamics profile of KN5501 cell injection in adults with systemic lupus erythematosus(SLE). It will also learn if KN5501 cell injection works to treat refractory SLE. The main questions it …
Phase: PHASE1 • Sponsor: Ruitherapeutics Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New male contraceptive device aims to be reversible
Disease control Recruiting nowProspective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive System to occlude the vas deferens to block the passage of sperm and then be reversed to subsequently allow the passage of s…
Phase: PHASE2 • Sponsor: Next Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Armored cells take on tough lymphoma in early trial
Disease control Recruiting nowThe purpose of this study is to investigate the safety and tolerability of anti-PD1 armored CD19 CAR-T Cells in adult subjects with relapsed or refractory diffuse large B-cell lymphoma.
Phase: PHASE1 • Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug duo takes on stubborn Epstein-Barr virus
Disease control Recruiting nowThis study is a multicenter, prospective, single-arm clinical investigation, with patients with CAEBVD as the main research subjects, to evaluate the effectiveness of the combined treatment regimen of golidocitinib and selinexor.
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New stent procedure offers hope for High-Risk aortic tear patients
Disease control Recruiting nowThis study is a single-arm, open-label, multi-center clinical trial evaluating the safety and efficacy of endovascular treatment for retrograde dissection involving the ascending aorta that is not suitable for open surgery. The aim is to assess the short-term (30 days) and medium…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New cocktail aims to shrink head and neck tumors before surgery
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of a novel combination therapy for locally advanced head and neck squamous cell carcinoma (HNSCC). The therapy combines the JAK1 inhibitor Sulfamethoxazole, the anti-PD-L1 antibody Adebrelimab, and chemotherap…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Liver cancer screening trial aims to cut deaths in cirrhosis patients
Prevention Recruiting nowThis study aims to investigate whether repeated 6-monthly screening for hepatocellular carcinoma (HCC) - called "HCC surveillance" - offered to selected patients with chronic liver disease can reduce HCC-related mortality by facilitating earlier detection of HCC. The screening pr…
Phase: NA • Sponsor: University of Aarhus • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
New combo aims to treat brain metastases while protecting memory
Disease control Recruiting nowThis is a single-arm, multicenter, open-label, phase Ⅱ exploratory clinical study, which plans to enroll 74 treatment-naive patients with EGFR-sensitive mutations (exon 19 deletion, exon 21 L858R mutation) and symptomatic brain metastases from non-small cell lung cancer (NSCLC). …
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Growing new skin in minutes: a breakthrough for chronic wounds?
Disease control Recruiting nowThis multicenter real-world study evaluates the efficacy and safety of a novel technique for rapid intraoperative construction of tissue-engineered skin using autologous epidermal stem cells (EpiSCs) for repairing difficult-to-heal wounds. Eligible patients are randomized to rece…
Phase: NA • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a simple steroid dose before hip surgery prevent confusion in seniors?
Disease control CompletedThis single-center, prospective, randomized, double-blind, placebo-controlled trial was conducted at the Department of Orthopaedic Surgery, JPMC, Karachi. Patients aged ≥60 years with hip fractures were randomized 1:1 to receive either intravenous dexamethasone or a placebo preop…
Phase: NA • Sponsor: Jinnah Postgraduate Medical Centre • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Video games may unlock a new path to treat dyslexia
Disease control Recruiting nowDevelopmental dyslexia is a common and serious specific learning disability affecting up to one in eight children in Hong Kong, with profound consequences for academic success and personal well-being. For children learning to read the visually complex Chinese script, the challeng…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC